Allarity Therapeutics, Inc. (ALLR) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending December 2025, Allarity Therapeutics, Inc. (NASDAQ:ALLR) is held by 15 institutional firms.

• The percentage of Allarity Therapeutics owned by institutions changed from 7.0% in September 2025 to 8.7% in December 2025, marking a slight up trend.
• Institutional share ownership changed by 25.06% QoQ, while the number of institutional owners saw an increase of 114.29% YoY.
• Among the 15 institutional holders of Allarity Therapeutics, 10 added to their stakes while 3 trimmed their positions and 2 held steady.
• The total number of shares held by institutions in Allarity Therapeutics increased to 1.29Mn as of December 2025, a net change of up by 258.92K shares quarter on quarter, and up 1.19Mn shares year over year.
• With 247.61K shares, RENAISSANCE TECHNOLOGIES LLC commands the largest institutional position in Allarity Therapeutics as of December 31, 2025, equating to 1.68% of the company.
• Among the most significant buyers of Allarity Therapeutics during December 2025 were RENAISSANCE TECHNOLOGIES LLC (181.43K), DRW Securities, LLC (122.74K), CAPITAL ADVISORS INC/OK (100.00K), XTX Topco Ltd (33.64K), UBS Group AG (26.52K).
• Leading sellers of Allarity Therapeutics stock in December 2025 included Private Advisor Group, LLC (223.41K), NORTHERN TRUST CORP (14.68K), CITADEL ADVISORS LLC (9.55K).
• The top 10 institutional holders of Allarity Therapeutics for the quarter ending December 2025 included RENAISSANCE TECHNOLOGIES LLC (247.61K), VANGUARD GROUP INC (246.71K), GEODE CAPITAL MANAGEMENT, LLC (156.64K), STATE STREET CORP (137.60K), DRW Securities, LLC (122.74K), CAPITAL ADVISORS INC/OK (100.00K), CITADEL ADVISORS LLC (84.59K), Private Advisor Group, LLC (55.54K), XTX Topco Ltd (33.64K), NORTHERN TRUST CORP (28.94K).